Table 4 Stage distribution for patients in the study (all patients dived between intervention and controls), and only for patients for whom the GP was involved in the diagnosis
All patients | Controls, all | Intervention, all | P-value | Controls, involved | Intervention, involved | p-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |||
Stage IA | 46 | (13.9) | 19 | (11.9) | 27 | (15.8) | 4 | (4.9) | 11 | (11.3) | ||
Stage IB | 33 | (10.0) | 18 | (11.3) | 15 | (8.8) | 8 | (9.8) | 8 | (8.3) | ||
Stage IIA | 14 | (4.2) | 3 | (1.9) | 3 | (1.8) | 3 | (3.7) | 3 | (3.1) | ||
Stage IIB | 22 | (6.6) | 11 | (6.9) | 11 | (6.4) | 7 | (8.5) | 7 | (7.2) | ||
Stage IIIA | 22 | (6.6) | 9 | (5.5) | 13 | (7.6) | 5 | (6.1) | 6 | (6.2) | ||
Stage IIIB | 24 | (7.3) | 12 | (7.5) | 12 | (7.0) | 7 | (8.5) | 9 | (9.3) | ||
Stage IV | 170 | (51.4) | 88 | (55.0) | 90 | (52.6) | 0.586a | 48 | (58.5) | 53 | (54.6) | 0.470a |
Localised (IA-IIIA) | 137 | (41.4) | 60 | (37.5) | 69 | (40.4) | 0.595b | 27 | (32.9) | 35 | (36.1) | 0.658b |
Metastatic (IIIB-IV) | 194 | (58.6) | 100 | (62.5) | 102 | (59.6) | 55 | (67.1) | 62 | (63.9) | ||